Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3176431 | 1.00 | LMNA (0.38) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL8433131 | 1.00 | LMNA (0.38) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL4872961 | 1.00 | LMNA (0.38) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL3331317 | 1.00 | LMNA (0.38) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL3170404 | 1.00 | — | — | |
| SCHEMBL8433135 | 1.00 | LMNA (0.38) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL3046759 | 1.00 | LMNA (0.38) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL8433677 | 1.00 | LMNA (0.38) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL4874291 | 1.00 | LMNA (0.38) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL3174948 | 1.00 | LMNA (0.38) | LMNAALDH1A1HSD17B10MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2486967-A2 | DEFOAMING AGENT | San Nopco Limited (JP) | 2012-08-15 | — | — | EP | disclosed |
| US-7378551-B2 | Amide compound | KAO CORPORATION (JP) | 2008-05-27 | — | — | US | disclosed |
| US-20070185208-A1 | Amide compound | KAO CORPORATION (JP) | 2007-08-09 | — | — | US | disclosed |
| US-5929283-A | HYDROXY AMINES; LOW IN IRRITATIVENESS TO THE SKIN AND HAIR AND EXCELLENT IN FOAMABILITY, AND CAN GIVE A PLEASANT FEELING TO THE USER'S SKIN | KAO CORPORATION (JP) | 1999-07-27 | — | — | US | disclosed |
| US-5885955-A | MILDNESS, LATHERABILITY, EMULSION STABILITY | KAO CORPORATION (JP) | 1999-03-23 | — | — | US | disclosed |
| US-5801270-A | Amine derivative and detergent composition containing the same | KAO CORPORATION (JP) | 1998-09-01 | — | — | US | disclosed |
| EP-0740651-B1 | AMINE DERIVATIVE AND DETERGENT COMPOSITION CONTAINING THE SAME | KAO CORP (JP) | 1998-08-12 | — | — | EP | disclosed |
| US-5756784-A | LATHERABILITY; EMULSION STABILITY | KAO CORPORATION (JP) | 1998-05-26 | — | — | US | disclosed |
| EP-0514588-B1 | Novel phosphobetaine and detergent and cosmetic containing the same | KAO CORP (JP) | 1997-06-11 | — | — | EP | disclosed |
| EP-0740651-A1 | AMINE DERIVATIVE AND DETERGENT COMPOSITION CONTAINING THE SAME | Kao Corporation (JP) | 1996-11-06 | — | — | EP | disclosed |
| WO-1995016664-A1 | AMINE DERIVATIVE AND DETERGENT COMPOSITION CONTAINING THE SAME | KAO CORPORATION (JP) | 1995-06-22 | — | — | WO | disclosed |
| US-5409705-A | Phosphobetaine and detergent and cosmetic containing the same | KAO CORPORATION (JP) | 1995-04-25 | — | — | US | disclosed |
| EP-0514588-A2 | Novel phosphobetaine and detergent and cosmetic containing the same | Kao Corporation (JP) | 1991-11-25 | — | — | EP | disclosed |
| US-5066648-A | Transdermal drug delivery, viricides, enzyme inhibitors | MERCK & CO., INC. (US) | 1991-11-19 | — | — | US | disclosed |
| US-4970206-A | TRANSDERMAL DRUG DELIVERY | MERCK & CO., INC. (US) | 1990-11-13 | — | — | US | disclosed |
| US-4847250-A | HYPOTENSIVE AGENTS | MERCK & CO., INC. (US) | 1989-07-11 | — | — | US | disclosed |
| US-4762851-A | ANTIINFLAMMATORY AGENTS | MERCK & CO., INC. (US) | 1988-08-09 | — | — | US | disclosed |
| EP-0227531-A2 | Pyroglutamic acid esters used as dermal penetration enhancers for drugs | MERCK & CO. INC. (US) | 1987-07-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185208-A1 | Amide compound | H1-0, H1-2, H1-4 | LMNA 1595/4885ALDH1A1 1773/4885HSD17B10 1160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.